Methods for detecting ovarian cancer
CA 2481093 A1 · Owner: Kishi, Tadaaki · Inventors: Kishi, Tadaaki; Diamandis, Eleftherios
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
A method for detecting a kallikrein 8 polypeptide associated with ovarian cancer in a patient is provided comprising detecting kallikrein 8 polypeptide in a sample from the patient. Methods are also provided for monitoring the progression of ovarian cancer in a patient determining whether ovarian cancer , has metastasized or is likely to metastasize in the future and assessing the , aggressiveness or indolence of ovarian cancer. In addition methods for , assessing the potential efficacy of a test agent for inhibiting ovarian cancer in a patient, selecting an agent for inhibiting ovarian cancer in a patient and assessing the ovarian cancer cell carcinogenic potential of a test compound …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed April 4, 2003. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended April 4, 2023.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by April 4, 2025.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.